Dr. Peter Luo |
Chairman of the Board, Chief Executive Officer, Co-Founder |
|
- |
Male |
|
Mr. Tam Man Kin |
Chief Financial Officer, Director |
|
- |
Male |
|
Dr. Zha Jiping |
Executive Vice President of Clinical Development |
|
- |
Male |
|
Dr. Shang Jin |
Senior Vice President of Global Regulatory Affairs |
|
- |
Female |
|
Ms. She Xiaohong |
Senior Vice President, Head of Clinical Operations |
|
- |
Female |
|
Ms. Li Yan |
Senior Vice President of Bioinformatics and Information Technology |
|
- |
Female |
|
Dr. Fangyong Du |
Chief Technology Officer |
|
- |
Male |
|
Dr. Xu Jc |
Chief Scientific Officer |
|
- |
Female |
|
Ms. Ami Knoefler |
Vice President of Investor Relations and Corporate Communications |
|
- |
Female |
|
Dr. Dana Hu - Lowe |
Vice President of Pipeline and Clinical Programs Management |
|
- |
Female |
|
Dr. Zeng Wenlin |
Vice President of Cell Line and Upstream |
|
- |
Female |
|
Dr. Zheng Songmao |
Associate Vice President of Research and Development |
|
- |
Male |
|
Ms. Gu Chunfang |
Senior Director of Finance |
|
- |
Female |
|
Ms. Zhou Ling |
Senior Director of Human Resources |
|
- |
Female |
|
Mr. Alexander Goergen |
Head of Business Development |
|
- |
Male |
|
Dr. Liu Guizhong |
Head of Biology and Pharmacology |
|
- |
Male |
|
Mr. Zhao Qinghai |
Chief Manufacturing Officer |
|
- |
Male |
|
Dr. Wang Yuren |
Head of Portfolio Management |
|
- |
Male |
|
Mr. Lefei Sun |
Director |
43 |
- |
Male |
|
Mr. Cheung Andy |
Independent Director |
|
- |
Male |
|
Ms. Yuwen Liu |
Independent Director |
|
- |
Female |
|
Dr. Li Min |
Independent Director |
|
- |
Male |
|